_256_384.jpeg)
The company aims to continue its expansion via organic and inorganic routes to increase production capacity and product portfolio
Acquisition of medical equipment distributor aims to strengthen European commercial operations and optimise distribution costs
The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe
This strategic acquisition enables CORONA Remedies to penetrate deeper into targeted specialty and offer wider accessibility
Pivya is Alembic’s first branded pharmaceutica product in the US and is being marketed through Alembic Therapeutics LLC
VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets
Under the deal, Quiver will receive an undisclosed advance payment and research support
Net sales reached CHF 1,327.8 million, up 2.6% year-on-year in Swiss francs, or 4.3% at constant exchange rates
The company has posted net profit of Rs. 4,064.9 crore for the 9 months period ended December 31, 2025
The deal to acquire AT-01 (124-Iodine-evuzamitide) and AT-05 (PAR-Peptide + technetium-99m) underscores Bayer’s commitment to expanding in molecular imaging and advancing precision cardiology
Subscribe To Our Newsletter & Stay Updated
